Sarepta Therapeutics Cash Flow from Financial Activities 2010-2025 | SRPT
Sarepta Therapeutics cash flow from financial activities for the twelve months ending March 31, 2025 was $0.275B, a 27.18% decline year-over-year.
- Sarepta Therapeutics annual cash flow from financial activities for 2024 was $0.125B, a 0.16% decline from 2023.
- Sarepta Therapeutics annual cash flow from financial activities for 2023 was $0.125B, a 46.24% decline from 2022.
- Sarepta Therapeutics annual cash flow from financial activities for 2022 was $0.233B, a 58.6% decline from 2021.